LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-6.40 Cr | ₹-5.18 Cr | ₹-4.50 Cr | ₹-2.56 Cr | ₹-5.75 Cr |
What is the latest Cash Flow from Financing Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-6.40 Cr |
| Mar2024 | ₹-5.18 Cr |
| Mar2023 | ₹-4.50 Cr |
| Mar2022 | ₹-2.56 Cr |
| Mar2021 | ₹-5.75 Cr |
How is Cash Flow from Financing Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-6.40 Cr | Negative | |
| Mar2024 | ₹-5.18 Cr | Negative | |
| Mar2023 | ₹-4.50 Cr | Negative | |
| Mar2022 | ₹-2.56 Cr | Negative | |
| Mar2021 | ₹-5.75 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,193.1 Cr | -1% | -4.1% | 5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1% |
-4.1% |
5.7% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses